Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Schuuring

Showing results (151-160 of 210) with videos related to

Pageof 21
Sort By:
ESMO Open|September 24, 2020
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancerSamantha O Perakis, Sabrina Weber, Qing Zhou, et al.
International Journal of Cancer|June 1, 2006
Assessment of gene promoter hypermethylation for detection of cervical neoplasiaG Bea A Wisman, Esther R Nijhuis, Mohammad O Hoque, et al.
Plos One|July 23, 2014
Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-offAniek Boers, Lorian Slagter-Menkema, Bettien M van Hemel, et al.
Epigenetics|August 7, 2018
Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancerWina Verlaat, Robert W Van Leeuwen, Putri W Novianti, et al.
Molecular Diagnosis & Therapy|June 10, 2016
FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell CarcinomaKoos Koole, Martijn J A M Clausen, Robert J J van Es, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2014
Head and neck squamous cell carcinomas do not express EGFRvIIILieuwe J Melchers, Martijn J A M Clausen, Mirjam F Mastik, et al.
Preventive Medicine Reports|March 17, 2023
The effect of extended participation windows on attendance at cervical cancer screeningKelly M Castañeda, Grigory A Sidorenkov, Jolien de Waard, et al.
Pharmacoeconomics|February 7, 2025
Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in OncologyAstrid Kramer, Lucas F van Schaik, Daan van den Broek, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Lung Cancer in the NetherlandsLizza E L Hendriks, Anne-Marie C Dingemans, Dirk K M De Ruysscher, et al.
Breast Cancer Research : BCR|June 15, 2012
Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approachTim J A Dekker, Susan Ter Borg, Gerrit K J Hooijer, et al.
Pageof 21

Showing results (151-160 of 210) with videos related to

Sort By:
Pageof 21
ESMO Open|September 24, 2020
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancerSamantha O Perakis, Sabrina Weber, Qing Zhou, et al.
International Journal of Cancer|June 1, 2006
Assessment of gene promoter hypermethylation for detection of cervical neoplasiaG Bea A Wisman, Esther R Nijhuis, Mohammad O Hoque, et al.
Plos One|July 23, 2014
Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-offAniek Boers, Lorian Slagter-Menkema, Bettien M van Hemel, et al.
Epigenetics|August 7, 2018
Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancerWina Verlaat, Robert W Van Leeuwen, Putri W Novianti, et al.
Molecular Diagnosis & Therapy|June 10, 2016
FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell CarcinomaKoos Koole, Martijn J A M Clausen, Robert J J van Es, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2014
Head and neck squamous cell carcinomas do not express EGFRvIIILieuwe J Melchers, Martijn J A M Clausen, Mirjam F Mastik, et al.
Preventive Medicine Reports|March 17, 2023
The effect of extended participation windows on attendance at cervical cancer screeningKelly M Castañeda, Grigory A Sidorenkov, Jolien de Waard, et al.
Pharmacoeconomics|February 7, 2025
Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in OncologyAstrid Kramer, Lucas F van Schaik, Daan van den Broek, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Lung Cancer in the NetherlandsLizza E L Hendriks, Anne-Marie C Dingemans, Dirk K M De Ruysscher, et al.
Breast Cancer Research : BCR|June 15, 2012
Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approachTim J A Dekker, Susan Ter Borg, Gerrit K J Hooijer, et al.
Pageof 21